FDA Inspection 1211473 — Biorez, Inc

Biorez, Inc — FEI 3019101334

The FDA completed an inspection of Biorez, Inc on August 4, 2023 in New Haven, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 4, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
New Haven, CT (United States)

Citations

IDCFRDescription
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures